v3.26.1
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive (Loss) Income, net
Beginning Balance at Dec. 31, 2024 $ 327,788 $ 322,791 $ 29,687 $ 17,772 $ (42,462)
Beginning Balance, Shares at Dec. 31, 2024   84,972,610      
Net loss (434)     (434)  
Other comprehensive income (loss) 3,806       3,806
Exercises of warrants to purchase common stock 6,905 $ 6,905      
Exercises of warrants to purchase common stock, Shares   2,762,000      
Restricted stock award grants and related compensation expense 275 $ 275      
Restricted stock award grants and related compensation expense, Shares   96,322      
Restricted stock award forfeitures and cancellations (51) $ (51)      
Restricted stock award forfeitures and cancellations, Shares   (53,083)      
Ending Balance at Mar. 31, 2025 338,289 $ 329,920 29,687 17,338 (38,656)
Ending Balance, Shares at Mar. 31, 2025   87,777,849      
Beginning Balance at Dec. 31, 2025 323,691 [1] $ 331,917 23,552 (659) (31,119)
Beginning Balance, Shares at Dec. 31, 2025   91,475,278      
Net loss 836     836  
Other comprehensive income (loss) (181)       (181)
Dividends on common stock (47,617)     (47,617)  
Restricted stock award grants and related compensation expense 272 $ 272      
Restricted stock award grants and related compensation expense, Shares   694,829      
Restricted stock award forfeitures and cancellations (37) $ (37)      
Restricted stock award forfeitures and cancellations, Shares   (2,373,114)      
Ending Balance at Mar. 31, 2026 $ 276,964 $ 332,152 $ 23,552 $ (47,440) $ (31,300)
Ending Balance, Shares at Mar. 31, 2026   89,796,993      
[1] Derived from audited December 31, 2025 Consolidated Financial Statements.